Long term outcomes in adult heart transplant recipients treated with OKT3 versus daclizumab induction therapy. 7th American Transplant Congress Virani, S. A., Ransohoff, K., Haddad, F., Valantine, H. A., Chin, C. WILEY-BLACKWELL. 2007: 424–424

View details for Web of Science ID 000246370201514